Towards establishing a method to screen for inhibitors of essential genes in mycobacteria

evaluation of the acetamidase promoter

Tirumalai R. Raghunand, William Ramses Bishai, Ping Chen

Research output: Contribution to journalArticle

Abstract

As a successful pathogen, Mycobacterium tuberculosis has effectively infected one-third of the world's population. Despite the existence of compound libraries developed by recent advances in combinatorial chemistry, few compounds have been screened against M. tuberculosis. The use of a regulable promoter to control the level of expression of a drug target in living organisms has been shown to be advantageous compared with targetless whole-cell-based or in vitro biochemical screening approaches towards antibiotic discovery. In this study, we demonstrate that the acetamidase promoter from Mycobacterium smegmatis responds in a dose-dependent manner to different concentrations of its inducer acetamide. Using this promoter to regulate expression of a zeocin resistance gene in M. smegmatis, we show that the test strain exhibits increased sensitivity to zeocin at a low concentration of acetamide compared with a fully resistant phenotype at high doses of the inducer. This model system has indicated the feasibility of using a regulable promoter in designing a whole-cell-based high throughput screen for specific inhibitors against potential drug targets of M. tuberculosis.

Original languageEnglish (US)
Pages (from-to)36-41
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume28
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Essential Genes
Mycobacterium
Mycobacterium tuberculosis
Mycobacterium smegmatis
Pharmaceutical Preparations
Libraries
Anti-Bacterial Agents
Phenotype
Population
Genes
acetamidase
Zeocin
acetamide

Keywords

  • Acetamidase promoter
  • Dose-response
  • Inhibitors
  • Mycobacterium tuberculosis

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

@article{dc92f5953cb6467187fa890e9118d17c,
title = "Towards establishing a method to screen for inhibitors of essential genes in mycobacteria: evaluation of the acetamidase promoter",
abstract = "As a successful pathogen, Mycobacterium tuberculosis has effectively infected one-third of the world's population. Despite the existence of compound libraries developed by recent advances in combinatorial chemistry, few compounds have been screened against M. tuberculosis. The use of a regulable promoter to control the level of expression of a drug target in living organisms has been shown to be advantageous compared with targetless whole-cell-based or in vitro biochemical screening approaches towards antibiotic discovery. In this study, we demonstrate that the acetamidase promoter from Mycobacterium smegmatis responds in a dose-dependent manner to different concentrations of its inducer acetamide. Using this promoter to regulate expression of a zeocin resistance gene in M. smegmatis, we show that the test strain exhibits increased sensitivity to zeocin at a low concentration of acetamide compared with a fully resistant phenotype at high doses of the inducer. This model system has indicated the feasibility of using a regulable promoter in designing a whole-cell-based high throughput screen for specific inhibitors against potential drug targets of M. tuberculosis.",
keywords = "Acetamidase promoter, Dose-response, Inhibitors, Mycobacterium tuberculosis",
author = "Raghunand, {Tirumalai R.} and Bishai, {William Ramses} and Ping Chen",
year = "2006",
month = "7",
doi = "10.1016/j.ijantimicag.2006.01.012",
language = "English (US)",
volume = "28",
pages = "36--41",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Towards establishing a method to screen for inhibitors of essential genes in mycobacteria

T2 - evaluation of the acetamidase promoter

AU - Raghunand, Tirumalai R.

AU - Bishai, William Ramses

AU - Chen, Ping

PY - 2006/7

Y1 - 2006/7

N2 - As a successful pathogen, Mycobacterium tuberculosis has effectively infected one-third of the world's population. Despite the existence of compound libraries developed by recent advances in combinatorial chemistry, few compounds have been screened against M. tuberculosis. The use of a regulable promoter to control the level of expression of a drug target in living organisms has been shown to be advantageous compared with targetless whole-cell-based or in vitro biochemical screening approaches towards antibiotic discovery. In this study, we demonstrate that the acetamidase promoter from Mycobacterium smegmatis responds in a dose-dependent manner to different concentrations of its inducer acetamide. Using this promoter to regulate expression of a zeocin resistance gene in M. smegmatis, we show that the test strain exhibits increased sensitivity to zeocin at a low concentration of acetamide compared with a fully resistant phenotype at high doses of the inducer. This model system has indicated the feasibility of using a regulable promoter in designing a whole-cell-based high throughput screen for specific inhibitors against potential drug targets of M. tuberculosis.

AB - As a successful pathogen, Mycobacterium tuberculosis has effectively infected one-third of the world's population. Despite the existence of compound libraries developed by recent advances in combinatorial chemistry, few compounds have been screened against M. tuberculosis. The use of a regulable promoter to control the level of expression of a drug target in living organisms has been shown to be advantageous compared with targetless whole-cell-based or in vitro biochemical screening approaches towards antibiotic discovery. In this study, we demonstrate that the acetamidase promoter from Mycobacterium smegmatis responds in a dose-dependent manner to different concentrations of its inducer acetamide. Using this promoter to regulate expression of a zeocin resistance gene in M. smegmatis, we show that the test strain exhibits increased sensitivity to zeocin at a low concentration of acetamide compared with a fully resistant phenotype at high doses of the inducer. This model system has indicated the feasibility of using a regulable promoter in designing a whole-cell-based high throughput screen for specific inhibitors against potential drug targets of M. tuberculosis.

KW - Acetamidase promoter

KW - Dose-response

KW - Inhibitors

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=33745186670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745186670&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2006.01.012

DO - 10.1016/j.ijantimicag.2006.01.012

M3 - Article

VL - 28

SP - 36

EP - 41

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 1

ER -